EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism

Di Han, Binbin Ding iD, Pan Zheng, Jia Tan, Qi Meng iD, Wenying Zhang, Hao Chen, Ping'an Ma iD, Jun Lin iD

ACS Nano · 2026

DOI: 10.1021/acsnano.5c17428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Di Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China. Hauptthemen laut MEDLINE: Ferroptosis, Cholesterol, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Heilongjiang Province, National Natural Science Foundation of China, Changbai Talent Program of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCholesterolNanoparticlesAntineoplastic AgentsAuranofinSerum Albumin, HumanNeoplasmsHumansAnimalsMiceCell Line, TumorSterol O-Acyltransferase

Stichwörter der Autor:innen

albumin nanoparticlecholesterol metabolismferroptosisimmune activationlipid raft

Substanzen

CholesterolAntineoplastic AgentsAuranofinSerum Albumin, HumanSterol O-Acyltransferase

Autor:innen und Institutionen

  • Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China.
  • Key Laboratory of Superlight Materials & Surface Technology of Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin 150001, China.

ORCID-Profile: Binbin Ding, Qi Meng, Ping'an Ma, Jun Lin

Förderung

  • Natural Science Foundation of Heilongjiang Province
  • National Natural Science Foundation of China
  • Changbai Talent Program of Jilin Province
  • Heilongjiang Touyan Innovation Team Program

Zitieren

APA

Han, D., Ding, B., Zheng, P., Tan, J., Meng, Q., Zhang, W., Chen, H., Ma, P., & Lin, J. (2026). Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism. ACS Nano. https://doi.org/10.1021/acsnano.5c17428

Vancouver

Han D, Ding B, Zheng P, Tan J, Meng Q, Zhang W, et al. Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism. ACS Nano. 2026. doi:10.1021/acsnano.5c17428

BibTeX
@article{Han2026,
  author = {Han, Di and Ding, Binbin and Zheng, Pan and Tan, Jia and Meng, Qi and Zhang, Wenying and Chen, Hao and Ma, Ping'an and Lin, Jun},
  title = {Albumin Nanoparticles Co-Loaded with Dual Drugs for Enhanced Ferroptosis-Based Cancer Therapy through Modulating Cholesterol Metabolism},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c17428}
}
Kostenlos starten →